Invention Grant
- Patent Title: Immunotherapeutic compositions for the treatment of alzheimer's disease
-
Application No.: US15294618Application Date: 2016-10-14
-
Publication No.: US10335468B2Publication Date: 2019-07-02
- Inventor: Peter Blackburn , Stephen Grimes
- Applicant: MERCIA PHARMA, INC.
- Applicant Address: US NY New York
- Assignee: MERCIA PHARMA, INC.
- Current Assignee: MERCIA PHARMA, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K39/00
Abstract:
A safe and effective vaccine to prevent, slow, halt or reverse progression of Alzheimer's disease in human patients is disclosed. The vaccine includes Aβ1-42 or an beta amyloid self epitope (e.g. Aβ1-15, or other 7-mer or 15-mer peptide epitopes derived from Aβ1-42) conjugated to an immunogenic carrier (e.g. DT) formulated in a water-in-oil Th2-biased adjuvant/delivery system.
Public/Granted literature
- US20170106063A1 IMMUNOTHERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Public/Granted day:2017-04-20
Information query
